Squarepoint
CGON icon

Squarepoint’s CG Oncology CGON Stock Holding History

Squarepoint’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
+14,477
New +$946K ﹤0.01% 2876
2025
Q1 		– Sell
-10,907
Closed -$313K – 4670
2024
Q4 		$313K Buy
+10,907
New +$373K ﹤0.01% 4117

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint's CGON Position: Q2 2026 in Review

Squarepoint opened a new position in CG Oncology (CGON) in Q2 2026: 14,477 shares worth $1.03M. The stake represents ﹤0.01% of the portfolio and ranks #2876 among its holdings. This is a return to the name: Squarepoint previously reported a position in CGON as recently as Q4 2024.

Squarepoint first reported a position in CGON in Q4 2024 and has held it in 2 quarters since. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Squarepoint held 14,477 shares of CG Oncology worth $1.03M as of Q2 2026.
  • CG Oncology was a new Squarepoint position in Q2 2026.
  • CG Oncology made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2876 holding.
  • Squarepoint first reported a position in CG Oncology in Q4 2024 and has held it in 2 quarters since.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.